LOCUS       BCS47307                1273 aa            linear   VRL 06-JUL-2022
DEFINITION  surface glycoprotein [Severe acute respiratory syndrome coronavirus
            2].
ACCESSION   BCS47307
VERSION     BCS47307.1
DBSOURCE    accession LC603287.1
KEYWORDS    .
SOURCE      Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  ORGANISM  Severe acute respiratory syndrome coronavirus 2
            Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
            Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
            Betacoronavirus; Sarbecovirus; Betacoronavirus pandemicum.
REFERENCE   1
  AUTHORS   Okamura,S., Kashiwabara,A., Suzuki,H., Takekawa,S., Kamitani,W. and
            Ebina,H.
  TITLE     Novel live attenuated SARS-CoV-2 vaccine candidate: protective
            immunity without serious lung lesions
  JOURNAL   Unpublished
REFERENCE   2  (residues 1 to 1273)
  AUTHORS   Ebina,H., Okamura,S. and Kashiwabara,A.
  TITLE     Direct Submission
  JOURNAL   Submitted (29-JAN-2021) Contact:Hirotaka Ebina BIKEN Innovative
            Vaccine Research Alliance Laboratories, Virus Vaccine Group; 3-1
            Yamada-Oka, Suita, Osaka 565-0871, Japan
COMMENT     We acknowledge the NGS core facility of the Genome Information
            Research Center at the Research Institute for Microbial Diseases of
            Osaka University for the support in RNA sequencing and data
            analysis.
FEATURES             Location/Qualifiers
     source          1..1273
                     /organism="Severe acute respiratory syndrome coronavirus
                     2"
                     /isolate="2020/BIKEN/A50-18"
                     /host="Homo sapiens"
                     /db_xref="taxon:2697049"
     Protein         1..1273
                     /product="surface glycoprotein"
     Region          13..304
                     /region_name="SARS-CoV-like_Spike_S1_NTD"
                     /note="N-terminal domain of the S1 subunit of the Spike
                     (S) protein from Severe acute respiratory syndrome
                     coronavirus and related betacoronaviruses in the B
                     lineage; cd21624"
                     /db_xref="CDD:394950"
     Site            order(38,41..44,113,115,167,198..200,225,228,230..234,
                     281..283)
                     /site_type="other"
                     /note="trimer interface [polypeptide binding]"
                     /db_xref="CDD:394950"
     Region          319..541
                     /region_name="SARS-CoV-2_Spike_S1_RBD"
                     /note="receptor-binding domain of the S1 subunit of severe
                     acute respiratory syndrome coronavirus 2 Spike (S)
                     protein; cd21480"
                     /db_xref="CDD:394827"
     Site            order(319,321,357,381..383,386,390,394,396,413,516..517,
                     521)
                     /site_type="other"
                     /note="trimer interface [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            order(369..370,372,374,376..378,380,382,384..386,389..390,
                     392,428..430,515,517,519)
                     /site_type="other"
                     /note="cryptic epitope [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            order(417,446,449,453,455..456,475,486..487,489,493,496,
                     498,500..502,505)
                     /site_type="other"
                     /note="receptor binding site [polypeptide binding]"
                     /db_xref="CDD:394827"
     Site            438..508
                     /site_type="other"
                     /note="receptor binding motif"
                     /db_xref="CDD:394827"
     Region          543..1208
                     /region_name="SARS-CoV-like_Spike_SD1-2_S1-S2_S2"
                     /note="SD-1 and SD-2 subdomains, the S1/S2 cleavage
                     region, and the S2 fusion subunit of the spike (S)
                     glycoprotein from SARS-CoV-2 (COVID-19) and related
                     betacoronaviruses in the B lineage; cd22378"
                     /db_xref="CDD:411965"
     Site            order(603,616,657,709,717,801,1074,1098,1134,1158,1173,
                     1194)
                     /site_type="other"
                     /note="N-linked glycosylation sites [posttranslational
                     modification]"
                     /db_xref="CDD:411965"
     Site            order(672..676,678,683..688,690..709)
                     /site_type="other"
                     /note="S1/S2 cleavage region"
                     /db_xref="CDD:411965"
     Site            788..806
                     /site_type="other"
                     /note="fusion peptide"
                     /db_xref="CDD:411965"
     Site            816..833
                     /site_type="other"
                     /note="internal fusion peptide"
                     /db_xref="CDD:411965"
     Region          918..983
                     /region_name="heptad repeat 1"
                     /note="heptad repeat 1 [structural motif]"
                     /db_xref="CDD:411965"
     Region          1162..1203
                     /region_name="heptad repeat 2"
                     /note="heptad repeat 2 [structural motif]"
                     /db_xref="CDD:411965"
     CDS             1..1273
                     /gene="S"
                     /gene_synonym="spike glycoprotein"
                     /coded_by="LC603287.1:21563..25384"
                     /note="structural protein; spike protein"
ORIGIN      
        1 mfvflvllpl vssqcvnltt rtqlppaytn sftrgvyypd kvfrssvlhs tqdlflpffs
       61 nvtwfhaihv sgtngtkrfd npvlpfndgv yfasteksni irgwifgttl dsktqslliv
      121 nnatnvvikv cefqfcndpf lgvyyhknnk swmesefrvy ssannctfey vsqpflmdle
      181 gkqgnfknlr efvfknidgy fkiyskhtpi nlvrdlpqgf saleplvdlp iginitrfqt
      241 llalhrsylt pgdsssgwta gaaayyvgyl qprtfllkyn engtitdavd caldplsetk
      301 ctlksftvek giyqtsnfrv qptesivrfp nitnlcpfge vfnatrfasv yawnrkrisn
      361 cvadysvlyn sasfstfkcy gvsptklndl cftnvyadsf virgdevrqi apgqtgkiad
      421 ynyklpddft gcviawnsnn ldskvggnyn ylyrlfrksn lkpferdist eiyqagstpc
      481 ngvegfncyf plqsygfqpt ngvgyqpyrv vvlsfellha patvcgpkks tnlvknkcvn
      541 fnfngltgtg vltesnkkfl pfqqfgrdia dttdavrdpq tleilditpc sfggvsvitp
      601 gtntsnqvav lyqgvnctev pvaihadqlt ptwrvystgs nvfqtragcl igaehvnnsy
      661 ecdipigagi casyqtqtns prrarsvasq siiaytmslg aensvaysnn siaiptnfti
      721 svtteilpvs mtktsvdctm yicgdstecs nlllqygsfc tqlnraltgi aveqdkntqe
      781 vfaqvkqiyk tppikdfggf nfsqilpdps kpskrsfied llfnkvtlad agfikqygdc
      841 lgdiaardli caqkfngltv lpplltdemi aqytsallvg titsgwtfga gaalqipfam
      901 qmayrfngig vtqnvlyenq klianqfnsa igkiqdslss tasalgklqd vvnqnaqaln
      961 tlvkqlssnf gaissvlndi lsrldkveae vqidrlitgr lqslqtyvtq qliraaeira
     1021 sanlaatkms ecvlgqskrv dfcgkgyhlm sfpqsaphgv vflhvtyvpa qeknfttapa
     1081 ichdgkahfp regvfvsngt hwfvtqrnfy epqiittdnt fvsgncdvvi givnntvydp
     1141 lqpeldsfke eldkyfknht spdvdlgdis ginasvvniq keidrlneva knlneslidl
     1201 qelgkyeqyi kwpwyiwlgf iagliaivmv timlccmtsc csclkgccsc gscckfdedd
     1261 sepvlkgvkl hyt
//

